Trump Asks Supreme Court to Block Order Requiring Return of Wrongly Deported Migrant
The government said Judge Paula Xinis, who ordered that the administration return the migrant, Kilmar Armando Abrego Garcia, by Monday, had engaged in “district-court diplomacy.”
Elon Musk pushes back on Trump tariffs, with help of a pencil and economist Milton Friedman
The Tesla and SpaceX CEO said last year that “you need to be careful with tariffs.”
Democrats are forming an ‘assassination culture’ as Trump rises in power, new study reveals
“When people feel like they have no say, no future and no leadership offering vision, they become susceptible to radical ideation, and that’s when the memes turn into permission structures for real violence.”
Justice Dept. Tries to Use Executive Privilege to Muzzle Fired Pardon Attorney
A fight over the testimony of Elizabeth G. Oyer could have a ripple effect on whether other fired Justice Department lawyers speak publicly about their experiences.
RFK Jr. to Kick Off MAHA Tour on Fighting Chronic Disease
After a second measles death in West Texas, the health secretary is expected to begin a tour through the Southwest to showcase nutrition legislation, among other priorities.
Appeals Court Reinstates 2 Leaders of Federal Boards Fired by Trump
A full appeals court panel voted 7-4 to restore Cathy Harris and Gwynne Wilcox to their positions, setting up an expected Supreme Court finale.
European Union offers to remove industrial tariffs on US goods: ‘Ready for a good deal’
The European Union has floated a “zero-for-zero” tariff resolution with the Trump administration after 20% import levies were imposed by Washington last week.
Palestinian billionaire accused of building ‘terror infrastructure’ for Hamas is sued by Oct. 7 attack victims’ families
The naturalized US citizen was accused of providing an “essential part” of Hamas’ “terror infrastructure” by facilitating the construction of tunnels and rocket-launch sites.
As RFK Jr. Champions Chronic Disease Prevention, Key Research Is Cut
Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the start of the Trump administration.